{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:38:25Z","timestamp":1785494305518,"version":"3.56.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.schres.2024.12.015","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T06:26:30Z","timestamp":1735626390000},"page":"179-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Response to clozapine and its predictors in treatment-resistant schizophrenia spectrum disorders: A retrospective chart review"],"prefix":"10.1016","volume":"275","author":[{"given":"Rajkumar","family":"Sanahan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanteemar S.","family":"Sreeraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Suhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadisha","family":"Thirthalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesan","family":"Venkatasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2024.12.015_bb0005","first-page":"93","article-title":"The \u201cdelayed onset\u201d of antipsychotic action--an idea whose time has come and gone","volume":"31","author":"Agid","year":"2006","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.schres.2024.12.015_bb0010","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.4088\/JCP.09m05785yel","article-title":"An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis","volume":"72","author":"Agid","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2024.12.015_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/acps.12742","article-title":"International trends in clozapine use: a study in 17 countries","volume":"136","author":"Bachmann","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2024.12.015_bb0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.31887\/DCNS.2014.16.4\/mcarbon","article-title":"Clinical predictors of therapeutic response to antipsychotics in schizophrenia","volume":"16","author":"Carbon","year":"2014","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.schres.2024.12.015_bb0025","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.schres.2023.07.014","article-title":"Clozapine and its protective effect on all-cause, natural, and suicide mortality in patients with schizophrenia: a nationwide cohort study in Taiwan","volume":"268","author":"Chen","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.12.015_bb0030","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.MY20096AH1C","article-title":"Treatment-resistant schizophrenia: definition, predictors, and therapy options","volume":"82","author":"Correll","year":"2021","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2024.12.015_bb0035","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/schbul\/sbt137","article-title":"Using treatment response to subtype schizophrenia: proposal for a new paradigm in classification","volume":"39","author":"Farooq","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2024.12.015_bb0040","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/02698811221078746","article-title":"Using a statistical learning approach to identify sociodemographic and clinical predictors of response to clozapine","volume":"36","author":"Fonseca de Freitas","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2024.12.015_bb0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/0020764020907941","article-title":"The National Mental Health Survey of India (2016): prevalence, socio-demographic correlates and treatment gap of mental morbidity","volume":"66","author":"Gautham","year":"2020","journal-title":"Int. J. Soc. Psychiatry"},{"key":"10.1016\/j.schres.2024.12.015_bb0050","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/0269881116642745","article-title":"Factors associated with changes in hospitalisation in patients prescribed clozapine","volume":"30","author":"Gee","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2024.12.015_bb0055","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1017\/S0033291721000246","article-title":"Demographic and clinical variables associated with response to clozapine in schizophrenia: a systematic review and meta-analysis","volume":"51","author":"Griffiths","year":"2021","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2024.12.015_bb0060","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4103\/0019-5545.64592","article-title":"Indian research: focus on clozapine","volume":"52","author":"Grover","year":"2010","journal-title":"Indian J. Psychiatry."},{"key":"10.1016\/j.schres.2024.12.015_bb0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.schres.2023.08.029","article-title":"Effect of clozapine on suicidality in patients with schizophrenia at a university hospital in Turkey","volume":"268","author":"G\u00fcrcan","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.12.015_bb0070","article-title":"The clinical global impression-schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia","volume":"16\u201323","author":"Haro","year":"2003","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.schres.2024.12.015_bb0075","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2024.12.015_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41537-023-00423-3","article-title":"Non-prescribing of clozapine for outpatients with schizophrenia in real-world settings: the clinicians\u2019 perspectives","volume":"9","author":"Jakobsen","year":"2023","journal-title":"Schizophrenia (Heidelb.)"},{"key":"10.1016\/j.schres.2024.12.015_bb0085","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.schres.2016.04.010","article-title":"Predictors of long-term (\u2265 6 months) antipsychotic polypharmacy prescribing in secondary mental healthcare","volume":"174","author":"Kadra","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.12.015_bb0090","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/0269881118817387","article-title":"Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine","volume":"33","author":"Kesserwani","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2024.12.015_bb0095","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3389\/fpsyt.2018.00757","article-title":"The group of treatment resistant schizophrenias. Heterogeneity in treatment resistant schizophrenia (TRS)","volume":"9","author":"Kinon","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.schres.2024.12.015_bb0100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1017\/ipm.2018.47","article-title":"Treatment resistant schizophrenia - review and a call to action","volume":"36","author":"Lally","year":"2019","journal-title":"Ir. J. Psychol. Med."},{"key":"10.1016\/j.schres.2024.12.015_bb0110","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/070674371506001107","article-title":"Subtyping schizophrenia by treatment response: antipsychotic development and the central role of positive symptoms","volume":"60","author":"Lee","year":"2015","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.schres.2024.12.015_bb0115","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2024.12.015_bb0120","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1176\/ajp.151.12.1744","article-title":"Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome","volume":"151","author":"Lieberman","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2024.12.015_bb0125","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/3218","article-title":"The global burden of disease, 1990\u20132020","volume":"4","author":"Lopez","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.schres.2024.12.015_bb0130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.euroneuro.2022.12.011","article-title":"Prevention of suicide by clozapine in mental disorders: systematic review","volume":"69","author":"Masdrakis","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2024.12.015_bb0135","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1001\/jamapsychiatry.2019.1702","article-title":"Association with hospitalization and all-cause discontinuation among patients with schizophrenia on clozapine vs other oral second-generation antipsychotics: a systematic review and meta-analysis of cohort studies","volume":"76","author":"Masuda","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2024.12.015_bb0140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/epirev\/mxn001","article-title":"Schizophrenia: a concise overview of incidence, prevalence, and mortality","volume":"30","author":"McGrath","year":"2008","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.schres.2024.12.015_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/03007999709113338","article-title":"Treatment-resistant schizophrenia--the role of clozapine","volume":"14","author":"Meltzer","year":"1997","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.schres.2024.12.015_bb0150","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-med-050911-161504","article-title":"Update on typical and atypical antipsychotic drugs","volume":"64","author":"Meltzer","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.schres.2024.12.015_bb0155","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.schres.2023.09.028","article-title":"Influence of time to clozapine prescription on the clinical outcome","volume":"268","author":"Mu\u00f1oz-Manchado","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.12.015_bb0160","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s43045-021-00163-z","article-title":"Socio demographic, clinical, and side effect profile of patients on clozapine in Kashmir, North India","volume":"28","author":"Nazir","year":"2021","journal-title":"Middle East Curr. Psychiatry"},{"key":"10.1016\/j.schres.2024.12.015_bb0165","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/JCP.0b013e318267b3cd","article-title":"Predictors of clozapine response in patients with treatment-refractory schizophrenia: results from a Danish Register Study","volume":"32","author":"Nielsen","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2024.12.015_bb0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.schres.2024.02.035","article-title":"Response rates to sequential trials of antipsychotic medications according to algorithms or treatment guidelines in psychotic disorders. A systematic review and meta-analysis","volume":"268","author":"O\u2019Donoghue","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.12.015_bb0175","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neubiorev.2020.01.017","article-title":"Demographic and clinical features as predictors of clozapine response in patients with schizophrenia spectrum disorders: a systematic review and meta-analysis","volume":"111","author":"Okhuijsen-Pfeifer","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"10039","key":"10.1016\/j.schres.2024.12.015_bb0180","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","article-title":"Schizophrenia","volume":"388","author":"Owen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2024.12.015_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41537-019-0090-z","article-title":"The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research","volume":"6","author":"Potkin","year":"2020","journal-title":"NPJ Schizophr."},{"issue":"1","key":"10.1016\/j.schres.2024.12.015_bb0195","first-page":"14","article-title":"Sample size calculation in medical studies","volume":"6","author":"Pourhoseingholi","year":"2013","journal-title":"Gastroenterol Hepatol Bed Bench."},{"key":"10.1016\/j.schres.2024.12.015_bb0200","first-page":"51","article-title":"Clinical predictors of response to clozapine in patients with treatment resistant schizophrenia","volume":"44","author":"Rajkumar","year":"2011","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.schres.2024.12.015_bb0205","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1176\/appi.ajp.2015.14101329","article-title":"Early improvement as a predictor of later response to antipsychotics in schizophrenia: a diagnostic test review","volume":"172","author":"Samara","year":"2015","journal-title":"AJP"},{"key":"10.1016\/j.schres.2024.12.015_bb0210","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jamapsychiatry.2015.2955","article-title":"Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: a network meta-analysis","volume":"73","author":"Samara","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2024.12.015_bb0215","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/schbul\/sby095","article-title":"How many patients with schizophrenia do not respond to antipsychotic drugs in the short term? An analysis based on individual patient data from randomized controlled trials","volume":"45","author":"Samara","year":"2019","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2024.12.015_bb0220","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.schres.2021.08.005","article-title":"Predictors of response to pharmacological treatments in treatment-resistant schizophrenia - a systematic review and meta-analysis","volume":"236","author":"Sepp\u00e4l\u00e4","year":"2021","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.12.015_bb0225","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00406-019-01053-6","article-title":"Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study","volume":"270","author":"Shah","year":"2020","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2024.12.015_bb0230","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.schres.2021.07.040","article-title":"Antipsychotic treatment strategies for acute phase and treatment resistance in schizophrenia: a systematic review of the guidelines and algorithms","volume":"236","author":"Shimomura","year":"2021","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.12.015_bb0235","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis","volume":"209","author":"Siskind","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2024.12.015_bb0240","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1177\/0706743717718167","article-title":"Clozapine response rates among people with treatment-resistant schizophrenia: data from a systematic review and meta-analysis","volume":"62","author":"Siskind","year":"2017","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.schres.2024.12.015_bb0245","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/acps.13361","article-title":"Clozapine levels as a predictor for therapeutic response: a systematic review and meta-analysis","volume":"144","author":"Siskind","year":"2021","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2024.12.015_bb0250","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.schres.2020.05.057","article-title":"Do Indian patients with schizophrenia need half the recommended clozapine dose to achieve therapeutic serum level? An exploratory study","volume":"222","author":"Suhas","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.12.015_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2021.102693","article-title":"Risk mitigation with the use of clozapine - quo vadimus","volume":"61","author":"Suhas","year":"2021","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.schres.2024.12.015_bb0260","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/jamapsychiatry.2017.1322","article-title":"Real-world effectiveness of antipsychotic treatments in a Nationwide cohort of 29\u00a0823 patients with schizophrenia","volume":"74","author":"Tiihonen","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2024.12.015_bb0265","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/YIC.0000000000000086","article-title":"Delayed initiation of clozapine may be related to poor response in treatment-resistant schizophrenia","volume":"30","author":"\u00dc\u00e7ok","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2024.12.015_bb0270","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.psychres.2006.09.016","article-title":"Gender differences in response to antipsychotic treatment in outpatients with schizophrenia","volume":"153","author":"Usall","year":"2007","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2024.12.015_bb0275","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.schres.2015.07.045","article-title":"Correlation between delay in initiating clozapine and symptomatic improvement","volume":"168","author":"Yada","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.12.015_bb0280","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.psychres.2017.01.064","article-title":"The critical treatment window of clozapine in treatment-resistant schizophrenia: secondary analysis of an observational study","volume":"250","author":"Yoshimura","year":"2017","journal-title":"Psychiatry Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996424005152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996424005152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T19:44:52Z","timestamp":1737315892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996424005152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":54,"alternative-id":["S0920996424005152"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2024.12.015","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Response to clozapine and its predictors in treatment-resistant schizophrenia spectrum disorders: A retrospective chart review","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2024.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}